132 related articles for article (PubMed ID: 2759353)
1. Polio and rabies vaccines produced in continuous cell lines: a reality for Vero cell line.
Montagnon BJ
Dev Biol Stand; 1989; 70():27-47. PubMed ID: 2759353
[TBL] [Abstract][Full Text] [Related]
2. Experience with vero cells at Pasteur Mérieux Connaught.
Montagnon BJ; Vincent-Falquet JC; Saluzzo JF
Dev Biol Stand; 1999; 98():137-40; discussion 167. PubMed ID: 10494966
[TBL] [Abstract][Full Text] [Related]
3. Qualification of working cell banks for the Vero cell line to produce licensed human vaccines.
Vincent-Falquet JC; Peyron L; Souvras M; Moulin JC; Tektoff J; Patet J
Dev Biol Stand; 1989; 70():153-6. PubMed ID: 2759347
[TBL] [Abstract][Full Text] [Related]
4. The present status of rabies vaccine development and clinical experience with rabies vaccine.
Roumiantzeff M
Southeast Asian J Trop Med Public Health; 1988 Dec; 19(4):549-61. PubMed ID: 3070767
[TBL] [Abstract][Full Text] [Related]
5. Experience with the Vero cell line.
Montagnon BJ; Vincent-Falquet JC
Dev Biol Stand; 1998; 93():119-23. PubMed ID: 9737386
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of poliovirus excretion after vaccination of infants with two oral polio vaccines prepared on Vero cells or on primary monkey kidney cells.
Mallet L; Pelloquin F; Brigaud M; Caudrelier P; Bandet R; Xueref C; Fuchs F; Gibelin N; Goldman C; Moulin JC; de Fraipont F; Montagnon B; Peyron L; Aymard M
J Med Virol; 1997 May; 52(1):50-60. PubMed ID: 9131458
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and safety in adults of a new chromatographically purified Vero-cell rabies vaccine (CPRV): a randomized, double-blind trial with purified Vero-cell rabies vaccine (PVRV).
Lang J; Cetre JC; Picot N; Lanta M; Briantais P; Vital S; Le Mener V; Lutsch C; Rotivel Y
Biologicals; 1998 Dec; 26(4):299-308. PubMed ID: 10403033
[TBL] [Abstract][Full Text] [Related]
8. Anomalous observations on IPV and OPV vaccination.
John TJ
Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
[TBL] [Abstract][Full Text] [Related]
9. New approach to the production of concentrated and purified inactivated polio and rabies tissue culture vaccines.
van Wezel AL; van Steenis G; Hannik CA; Cohen H
Dev Biol Stand; 1978; 41():159-68. PubMed ID: 223908
[TBL] [Abstract][Full Text] [Related]
10. Inactivated polio vaccine: industrial production from micro-carrier Vero cells culture.
Montagnon BJ
Trop Geogr Med; 1985 Sep; 37(3):S40-1. PubMed ID: 4071633
[TBL] [Abstract][Full Text] [Related]
11. Pre-exposure purified vero cell rabies vaccine and concomitant routine childhood vaccinations: 5-year post-vaccination follow-up study of an infant cohort in Vietnam.
Lang J; Feroldi E; Vien NC
J Trop Pediatr; 2009 Feb; 55(1):26-31. PubMed ID: 18048461
[TBL] [Abstract][Full Text] [Related]
12. Developments in the production and quality control of poliovirus vaccines -- historical perspectives.
Furesz J
Biologicals; 2006 Jun; 34(2):87-90. PubMed ID: 16621594
[TBL] [Abstract][Full Text] [Related]
13. Comparison of sensitivity of VERO cell line versus primary monkey kidney cells in the detection of residual live polio virus during and after inactivation.
Montagnon BJ; Nicolas AJ; Fanget B; Peyron L
Dev Biol Stand; 1981; 47():151-5. PubMed ID: 6262146
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a new combined inactivated DPT-polio vaccine.
Drucker J; Soula G; Diallo O; Fabre P
Dev Biol Stand; 1986; 65():145-51. PubMed ID: 3030861
[TBL] [Abstract][Full Text] [Related]
15. [Studies on the manufacture and immunogenicity of purified rabies vaccines on humans Vero cell].
Yu W; Liu Z; Qian H; Lu H; Wang H; Li F; Dou Z
Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Feb; 22(1):17-9. PubMed ID: 11860837
[TBL] [Abstract][Full Text] [Related]
16. Comparative pre-clinical and clinical experience with oral polio vaccine produced on MRC-5 cells or on primary monkey kidney cells.
Prikazsky V; Leroux-Roels G; Van Damme P; Safary A; Colau B; Duchene M
Vaccine; 2005 Jul; 23(33):4219-27. PubMed ID: 15936120
[TBL] [Abstract][Full Text] [Related]
17. Vero-cell rabies vaccine produced using serum-free medium.
Frazatti-Gallina NM; Mourão-Fuches RM; Paoli RL; Silva ML; Miyaki C; Valentini EJ; Raw I; Higashi HG
Vaccine; 2004 Dec; 23(4):511-7. PubMed ID: 15530700
[TBL] [Abstract][Full Text] [Related]
18. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine.
Briggs DJ; Banzhoff A; Nicolay U; Sirikwin S; Dumavibhat B; Tongswas S; Wasi C
Bull World Health Organ; 2000; 78(5):693-8. PubMed ID: 10859864
[TBL] [Abstract][Full Text] [Related]
19. Production in Vero cells of an inactivated rabies vaccine from strain FRV/K for animal and human use.
el-Karamany RM
Acta Virol; 1987 Aug; 31(4):321-8. PubMed ID: 2892381
[TBL] [Abstract][Full Text] [Related]
20. Systematically experimental investigation on carcinogenesis or tumorigenicity of VERO cell lines of different karyotypes in nude mice in vivo used for viral vaccine manufacture.
Zhang DL; Ji L; Li LJ; Huang GS
Yi Chuan Xue Bao; 2004 Jul; 31(7):647-60. PubMed ID: 15473315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
